Menu

Vaxxinity, Inc. VAXX

Full chart Compare
Set alert

Price alert · VAXX

All alert types
0.00 USD -0.01 (-99.29%)

At closeNov 6, 2026, 4:00 PM EST

0.02 Day range 0.02
0.0001 52-week range 0.055
YTD
-66.67%
1 year
-99.33%

Revenue & Expenses

Net Loss → Expenses: $137.18MExpenses → Gross Loss: $1.87MExpenses → Selling, General & Admin: $51.83MExpenses → Research & Development: $71.38MExpenses → Interest Expense: $840.00KExpenses → Other Expenses: $11.26MRevenue → Cost of Revenue: $66.00KNet Loss$137.18MCost of Revenue$1.94MExpenses$137.18MGross Loss$1.87MSelling, General & Admin$51.83MResearch & Development$71.38MInterest Expense$840.00KOther Expenses$11.26MRevenue$66.00K

Latest period ending Dec 31, 2023 · select a line to chart its full history

VAXX annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-58.28M-75.98M-125.08M-32.28M-13.66M
-56.93M-75.22M-137.18M-39.96M-14.22M
-0.45-0.60-1.79-0.61-0.27
VAXX annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
5.04M34.57M145.06M31.20M476.00K
44.31M106.40M166.67M50.14M1.59M
30.90M44.22M38.05M75.04M23.29M
15.17M14.55M10.70M62.63M14.31M
13.41M62.18M128.62M-87.38M-48.51M
VAXX annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-57.24M-55.93M-80.99M-33.91M-12.27M
28.84M-54.39M-1.32M-1.48M0
-1.14M-167.00K196.17M196.17M11.14M
-803.00K-1.87M-1.32M-1.48M0
-29.53M-110.49M113.86M113.86M-1.13M